Tekla Healthcare Investors Stock Probability of Future Stock Price Finishing Under 22.62

HQH Stock  USD 15.83  0.05  0.32%   
Tekla Healthcare's future price is the expected price of Tekla Healthcare instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Tekla Healthcare Investors performance during a given time horizon utilizing its historical volatility. Check out Tekla Healthcare Backtesting, Tekla Healthcare Valuation, Tekla Healthcare Correlation, Tekla Healthcare Hype Analysis, Tekla Healthcare Volatility, Tekla Healthcare History as well as Tekla Healthcare Performance.
  
As of now, Tekla Healthcare's Price To Book Ratio is decreasing as compared to previous years. The Tekla Healthcare's current Price Sales Ratio is estimated to increase to 15.97, while Price Earnings To Growth Ratio is projected to decrease to (0.10). Please specify Tekla Healthcare's target price for which you would like Tekla Healthcare odds to be computed.

Tekla Healthcare Target Price Odds to finish below 22.62

The tendency of Tekla Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to stay under $ 22.62  after 90 days
 15.83 90 days 22.62 
close to 99
Based on a normal probability distribution, the odds of Tekla Healthcare to stay under $ 22.62  after 90 days from now is close to 99 (This Tekla Healthcare Investors probability density function shows the probability of Tekla Stock to fall within a particular range of prices over 90 days) . Probability of Tekla Healthcare Inv price to stay between its current price of $ 15.83  and $ 22.62  at the end of the 90-day period is close to 99 .
Considering the 90-day investment horizon Tekla Healthcare has a beta of 0.78. This usually indicates as returns on the market go up, Tekla Healthcare average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Tekla Healthcare Investors will be expected to be much smaller as well. Additionally Tekla Healthcare Investors has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
   Tekla Healthcare Price Density   
       Price  

Predictive Modules for Tekla Healthcare

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tekla Healthcare Inv. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Tekla Healthcare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
14.9615.7916.62
Details
Intrinsic
Valuation
LowRealHigh
15.3016.1316.96
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Tekla Healthcare. Your research has to be compared to or analyzed against Tekla Healthcare's peers to derive any actionable benefits. When done correctly, Tekla Healthcare's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Tekla Healthcare Inv.

Tekla Healthcare Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Tekla Healthcare is not an exception. The market had few large corrections towards the Tekla Healthcare's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Tekla Healthcare Investors, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Tekla Healthcare within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
-0.14
β
Beta against NYSE Composite0.78
σ
Overall volatility
0.31
Ir
Information ratio -0.2

Tekla Healthcare Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Tekla Healthcare for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Tekla Healthcare Inv can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Tekla Healthcare Inv generated a negative expected return over the last 90 days
Tekla Healthcare Inv has high likelihood to experience some financial distress in the next 2 years
Tekla Healthcare Investors has about 62 in cash with (65.41 M) of positive cash flow from operations.
On 28th of March 2024 Tekla Healthcare paid $ 0.48 per share dividend to its current shareholders
Latest headline from investing.com: Abdn healthcare investors director buys 8.6k in stock

Tekla Healthcare Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Tekla Stock often depends not only on the future outlook of the current and potential Tekla Healthcare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tekla Healthcare's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding49.4 M
Cash And Short Term Investments214.00

Tekla Healthcare Technical Analysis

Tekla Healthcare's future price can be derived by breaking down and analyzing its technical indicators over time. Tekla Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Tekla Healthcare Investors. In general, you should focus on analyzing Tekla Stock price patterns and their correlations with different microeconomic environments and drivers.

Tekla Healthcare Predictive Forecast Models

Tekla Healthcare's time-series forecasting models is one of many Tekla Healthcare's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Tekla Healthcare's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Tekla Healthcare Inv

Checking the ongoing alerts about Tekla Healthcare for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Tekla Healthcare Inv help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Tekla Healthcare Inv generated a negative expected return over the last 90 days
Tekla Healthcare Inv has high likelihood to experience some financial distress in the next 2 years
Tekla Healthcare Investors has about 62 in cash with (65.41 M) of positive cash flow from operations.
On 28th of March 2024 Tekla Healthcare paid $ 0.48 per share dividend to its current shareholders
Latest headline from investing.com: Abdn healthcare investors director buys 8.6k in stock
When determining whether Tekla Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tekla Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tekla Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tekla Healthcare Investors Stock:
Check out Tekla Healthcare Backtesting, Tekla Healthcare Valuation, Tekla Healthcare Correlation, Tekla Healthcare Hype Analysis, Tekla Healthcare Volatility, Tekla Healthcare History as well as Tekla Healthcare Performance.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Tekla Stock analysis

When running Tekla Healthcare's price analysis, check to measure Tekla Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tekla Healthcare is operating at the current time. Most of Tekla Healthcare's value examination focuses on studying past and present price action to predict the probability of Tekla Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tekla Healthcare's price. Additionally, you may evaluate how the addition of Tekla Healthcare to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is Tekla Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tekla Healthcare. If investors know Tekla will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tekla Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.67)
Dividend Share
1.61
Earnings Share
1.09
Revenue Per Share
0.208
Quarterly Revenue Growth
0.081
The market value of Tekla Healthcare Inv is measured differently than its book value, which is the value of Tekla that is recorded on the company's balance sheet. Investors also form their own opinion of Tekla Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Tekla Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tekla Healthcare's market value can be influenced by many factors that don't directly affect Tekla Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tekla Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tekla Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tekla Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.